- News Home
12 December 2013 1:00 pm ,
Vol. 342 ,
The iconic 125-year-old Lick Observatory on Mount Hamilton near San Jose, California, is facing the threat of closure...
Recent results from the Curiosity Mars rover have helped scientists formulate a plan for the next phase of its mission...
A new, remarkably powerful drug that cripples the hepatitis C virus (HCV) came to market last week, but it sells for $...
In pretoothbrush populations, gumlines would often be marred by a thick, visible crust of calcium phosphate, food...
Evolutionary biologists have long studied how the Mexican tetra, a drab fish that lives in rivers and creeks but has...
Victorian astronomers spent countless hours laboriously charting the positions of stars in the sky. Such sky mapping,...
In an ambitious project to study 1000 years of sickness and health, researchers are excavating the graveyard of the now...
Stefan Behnisch has won awards for designing science labs and other buildings that are smart, sustainable, and...
- 12 December 2013 1:00 pm , Vol. 342 , #6164
- About Us
Only 1.4% Boost for NIH From Senate Panel
29 July 2009 11:39 am
A Senate spending panel has matched President Barack Obama's request for funding for the National Institutes of Health in 2010—a $442 million boost to $31.8 billion. That slight 1.4% bump is less than half of the increase the House of Representatives approved last week. After the full committee and Senate approve the bill, it will be reconciled with the House version.
Like the president, the Senate appropriations labor, health and human services subcommittee, headed by Tom Harkin (D–IA), felt that NIH didn't need more money because the Recovery Act gave it $10 billion to spend through 2010. The bill "was greatly influenced" by the funding in the Act, a statement from the committee says. But the bill does not include the president's request for bigger boosts for cancer and autism research, according to Jennifer Zeitzer, director of legislative relations for the Federation of American Societies for Experimental Biology. FASEB is "pleased" because disease-specific allocations go against the serendipitous nature of scientific discovery, she says. FASEB is hoping for a higher overall number for NIH in the conference with the House.